Acebutolol, a Cardioselective Beta Blocker, Promotes Glucose Uptake in Diabetic Model Cells by Inhibiting JNK-JIP1 Interaction |
Li, Yi
(Department of Bio and Brain Engineering, KAIST)
Jung, Nan-Young (Department of Bio and Brain Engineering, KAIST) Yoo, Jae Cheal (Department of Bio and Brain Engineering, KAIST) Kim, Yul (Department of Bio and Brain Engineering, KAIST) Yi, Gwan-Su (Department of Bio and Brain Engineering, KAIST) |
1 | Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L. H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., Solinas, G., Karin, M. and Pellecchia, M. (2008) Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. U.S.A. 105, 16809-16813. DOI |
2 | Aguirre, V., Uchida, T., Yenush, L., Davis, R. and White, M. F. (2000) The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of . J. Biol. Chem. 275, 9047-9054. DOI |
3 | Barr, R. K., Kendrick, T. S. and Bogoyevitch, M. A. (2002) Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997. DOI |
4 | Bates, D. J., Lewis, L. D., Eastman, A. and Danilov, A. V. (2015) Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo. Br. J. Clin. Pharmacol. 80, 493-501. DOI |
5 | Bennett, B. L., Satoh, Y. and Lewis, A. J. (2003) JNK: a new therapeutic target for diabetes. Curr. Opin. Pharmacol. 3, 420-425. DOI |
6 | Charoenlarp, K. and Jaroonvesama, N. (1978) Clinical trial of acebutolol (Sectral) in hypertension. J. Int. Med. Res. 6, 67-71. DOI |
7 | Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. and Bourne, P. E. (2000) The protein data bank. Nucleic Acids Res. 28, 235-242. DOI |
8 | Bogoyevitch, M. A. and Arthur, P. G. (2008) Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim. Biophysica. Acta 1784, 76-93. DOI |
9 | Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B. and Rondinone, C. M. (2003) Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634-641. DOI |
10 | Deacon, S. P., Karunanayake, A. and Barnett, D. (1977) Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics. Br. Med. J. 2, 1255-1257. DOI |
11 | Fraser, D. M., Nimmo, G. R. and Poloniecki, J. D. (1986) Acebutolol in the treatment of diabetic patients with hypertension. Curr. Med. Res. Opin. 10, 122-127. DOI |
12 | Kim, D. J., Yi, Y. W. and Kim, J. H. (2008) In situ monitoring of bindings between dasatinib and its target protein kinases using magnetic nanoparticles in live cells. J. Am. Chem. Soc. 130, 16466-16467. DOI |
13 | Heo, Y. S., Kim, S. K., Seo, C. I., Kim, Y. K., Sung, B. J., Lee, H. S., Lee, J. I., Park, S. Y., Kim, J. H., Hwang, K. Y., Hyun, Y. L., Jeon, Y. H., Ro, S., Cho, J. M., Lee, T. G. and Yang, C. H. (2004) Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23, 2185-2195. DOI |
14 | Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M. and Hotamisligil, G. S. (2002) A central role for JNK in obesity and insulin resistance. Nature 420, 333-336. DOI |
15 | Kaneto, H., Xu, G., Fujii, N., Kim, S., Bonner-Weir, S. and Weir, G. C. (2002) Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 277, 30010-30018. DOI |
16 | Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J. and Bryant, S. H. (2016) PubChem Substance and Compound databases. Nucleic Acids Res. 44, D1202-D1213. DOI |
17 | Kumar, A., Singh, U. K., Kini, S. G., Garg, V., Agrawal, S., Tomar, P. K., Pathak, P., Chaudhary, A., Gupta, P. and Malik, A. (2015) JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases. Future Med. Chem. 7, 2065-2086. DOI |
18 | Rao, S. N., Head, M. S., Kulkarni, A. and LaLonde, J. M. (2007) Validation studies of the site-directed docking program LibDock. J. Chem. Inf. Model. 47, 2159-2171. DOI |